No abstract available
Recent Resources
OSDH COVID-19 Guidance for Healthcare Providers
No abstract available.
CDC COCA Call -- Coronavirus Disease 2019 (COVID-19) Update—What Clinicians Need to Know to Prepare for COVID-19 in the United States
During this COCA Call, clinicians will learn what they can do to prepare for COVID-19
including identifying persons under investigation, applying infection prevention and
control measures, assessing risks for exposures, optimizing the use of personal
protective equipment...
Pharmacotherapy for the Treatment of Cannabis Use Disorder: A Systematic Review
BACKGROUND:
Cannabis use disorder (CUD) is a growing concern, and evidence-based data are needed to inform treatment options.
PURPOSE:
To review the benefits and risks of pharmacotherapies for the treatment of CUD.
DATA SOURCES:
MEDLINE, PsycINFO, Cochrane...
Ameliorative Effects Of N-Acetylcysteine As Adjunct Therapy On Symptoms Of Painful Diabetic Neuropathy
PURPOSE:
Painful diabetic neuropathy (PDN) is a variant of diabetic peripheral neuropathy which is highly prevalent and distressing in diabetic patients. Despite its high burden, the optimal treatment of PDN has remained a clinical challenge. To explain the emergence and maintenance of...
Mental Health Conditions Among Patients Seeking and Undergoing Bariatric Surgery: A Meta-analysis
IMPORTANCE:
Bariatric surgery is associated with sustained weight loss and improved physical health status for severely obese individuals. Mental health conditions may be common among patients seeking bariatric surgery; however, the prevalence of these conditions and whether they are...
Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation
IMPORTANCE:
Patients with nonvalvular atrial fibrillation at risk of stroke should receive oral anticoagulants (OAC). However, approximately 1 in 8 patients in the Global Anticoagulant Registry in the Field (GARFIELD-AF) registry are treated with antiplatelet (AP) drugs in addition to OAC...